H&R Block insider files Form 4 showing RSU grant and $50.35 share sale
Rhea-AI Filing Summary
Insider transactions by Kellie J. Logerwell at H&R Block (HRB): The report shows two transactions on 08/31/2025. Ms. Logerwell, identified as Vice President & Chief Accounting Officer, was granted 2,086 restricted share units under the company's 2018 Long Term Incentive Plan at a price of $0.00; after that grant she beneficially owned 25,073.468 shares. The filing also records a disposition coded F of 2,947 common shares sold at $50.35, leaving her with 22,126.468 shares following the sale. The restricted share units vest in three equal installments beginning on the first anniversary of the grant date. The form is signed on behalf of the reporting person by Katharine M. Haynes per power of attorney on 09/03/2025.
Positive
- Compensation alignment: Grant of 2,086 restricted share units vests over three years, aligning executive incentives with long-term shareholder value
- Timely disclosure: Form 4 filed reporting both grant and sale, with signature executed via power of attorney
Negative
- Share reduction: Disposition of 2,947 shares at $50.35 reduced direct holdings from 25,073.468 to 22,126.468
- Potential dilution: New RSUs will increase share count when they vest, representing future dilution (amount disclosed: 2,086 RSUs)
Insights
TL;DR: Insider received restricted share units and sold a separate block of shares at $50.35, modestly reducing direct holdings.
The report records a non-derivative grant of 2,086 restricted share units (RSUs) awarded under HRB's 2018 Long Term Incentive Plan with an effective grant price of $0.00, indicating these are compensation RSUs rather than purchases. The RSUs vest in three equal installments beginning one year after grant, which creates a schedule of future equity dilution tied to continued service. Separately, the filing shows a disposition of 2,947 common shares at $50.35, decreasing the reporting person’s direct holdings from 25,073.468 to 22,126.468 shares. These are routine Section 16 transactions that disclose compensation and an executed sale; the filing does not state proceeds retained, reasons for sale, or any derivative activity beyond the RSU grant.
TL;DR: Transaction mix of RSU grant and contemporaneous sale is typical for executive compensation and portfolio management.
The document shows an executive-level officer receiving time-based restricted share units while also recording a separate sale of common stock. The RSU grant contains standard vesting language—three equal installments beginning on the first anniversary—consistent with retention incentives. The filing is complete for the reported transactions and executed under power of attorney, which is common practice for timely Section 16 compliance. No indications of option exercises, derivative hedging, or Rule 10b5-1 plan reliance are disclosed in this Form 4.